Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Bedside ultrasound measurement of the stomach antral area to predict enteral feeding intolerance

Official title: Bedside Observation by Clinical Ultrasound for Stomach Expansion

Run by Centre Hospitalier Saint Joseph Saint Luc de Lyon · NCT07312890 · Data updated 2026-11-12

This test uses an early bedside ultrasound of the stomach's antral area to see if it can predict which ventilated adult patients on tube feeding will later have poor gastric tolerance.

More Enteral Feeding Intolerance trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorCentre Hospitalier Saint Joseph Saint Luc de Lyon
Academic / other
Locations1 site (Lyon)
StatusRecruiting
StartedOctober 25, 2025
Main results expectedNovember 1, 2026
Study endsJanuary 25, 2027
Registry record updatedDecember 31, 2025
Trial IDNCT07312890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18) in the ICU who are predicted to need mechanical ventilation ≥48 hours and who have been started on enteral nutrition via a nasogastric or orogastric tube within the early 48–96 hour window.

Probably not a fit

Patients unlikely to benefit include those with prior major gastric surgery, those fed by gastrostomy/jejunostomy or jejunal tube, pregnant patients, patients with no ultrasound window, terminal prognosis, or those excluded for legal/social coverage reasons.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-center interventional protocol, clinicians perform a bedside gastric ultrasound to measure the antral cross-sectional area early after enteral nutrition is started. Measured antral area values are compared with subsequent clinical signs of poor gastric tolerance (for example high gastric residuals, vomiting, or need to stop/reduce feeding). The study enrolls adults expected to remain on mechanical ventilation for at least 48 hours and receiving enteral feeding via a nasogastric or orogastric tube within a defined early window. The aim is to determine whether that early ultrasound measurement predicts later feeding intolerance.

Why it matters

Potential benefit: If successful, this approach could help clinicians identify patients at high risk for feeding intolerance sooner and adapt feeding strategies to reduce complications.

How similar studies have gone: Prior studies using gastric ultrasound have shown good correlation between antral area and gastric volume or aspiration risk, but using an early antral-area measurement specifically to predict later enteral feeding intolerance is relatively novel and not yet widely proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Predicted mechanical ventilation ≥ 48 hours
* Initiation of enteral nutrition via nasogastric or orogastric tube for ≥ 48 hours
* Free and informed consent obtained from the patient's relative or legal representative, or inclusion in an emergency situation

Exclusion Criteria:

* History of major gastric surgery (bypass, total gastrectomy, biliopancreatic diversion)
* Enteral nutrition via nasogastric or orogastric tube \> 96 hours
* Initiation of enteral nutrition before intubation
* Feeding via gastrostomy, jejunostomy, or jejunal tube
* Pregnancy
* Prognosis considered terminal
* No ultrasound window available
* Legally protected adults (under curatorship, guardianship, or judicial protection)
* No social security coverage
* Patient under State Medical Aid (AME)

Where it's running

  • Hôpital Saint Joseph Saint Luc
    Lyon, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.